{"id":"doi:10.1161/circulationaha.117.028136","kind":"review","title":"Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors","authors":["Michael Albrecht Nauck","Juris Jendrik Meier","Matthew Aaron Cavender","Mirna S. Abd El Aziz","Daniel J. Drucker"],"author_count":5,"year":2017,"published":"2017-08-28","venue":"Circulation","cited_by":581,"doi":"10.1161/circulationaha.117.028136","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1161/circulationaha.117.028136","archive_url":"https://space-kitty.com/papers/doi:10.1161/circulationaha.117.028136","updated":null,"pmid":"28847797","pmcid":null,"openalex_id":"W2746874591","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Diabetes Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}